<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(1)</volume><submitter>Tang R</submitter><journal>Scientific reports</journal><pagination>2538</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12820069</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SLC45A2 drives prostate cancer progression through tumor promotion and immune suppression.</pubmed_title><pmcid>PMC12820069</pmcid><pubmed_authors>Wu Z</pubmed_authors><pubmed_authors>Liu K</pubmed_authors><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Tang R</pubmed_authors></additional><is_claimable>false</is_claimable><name>SLC45A2 drives prostate cancer progression through tumor promotion and immune suppression.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T19:35:47.951Z</modification><creation>2026-06-04T03:11:47.28Z</creation></dates><accession>S-EPMC12820069</accession><cross_references><pubmed>41398365</pubmed><doi>10.1038/s41598-025-32340-z</doi></cross_references></HashMap>